Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, June 4, 2014

Statins improve survival in patients with cardioembolic stroke

Well shit, doesn't anyone read research? Why was this even approved for research? Do review boards even know what existing research is out there? This was written about in March, 2011,

Acute statin therapy improves survival after ischemic stroke

By Nikki Withers

30 March 2011

Stupid, stupid, stupid
And I bet not a single hospital has created a stroke protocol to administer statins to all stroke survivors, it has only been 3 years.

The new one here;

http://www.mdlinx.com/internal-medicine/newsl-article.cfm/5302412/ZZF307965849E94474BB34FC062CEC0F93/?

Stroke, 06/03/2014 Clinical Article

Choi JY, et al. – The objective of this study was to investigate the potential benefits of statin therapy on mortality and stroke recurrence after cardioembolic stroke. Statin therapy could be associated with reduced mortality in patients with cardioembolic stroke.
Methods

In this retrospective observational study, the authors analyzed data from 535 patients with first–ever cardioembolic stroke.
Patients were classified into nonstatin, low–potency statin, and high–potency statin groups.
The primary outcomes were time to mortality and time to recurrent stroke.

Results

The mean duration of follow–up was 22.2 months.
The cumulative mortality rate was 7% at the end of the first year and 10% at the end of the third year.
Statin therapy was independently associated with reduced mortality (hazard ratio, 0.237; 95% confidence interval, 0.080–0.703 for nonstatin versus low–potency statin; hazard ratio, 0.158; 95% confidence interval, 0.037–0.686 for nonstatin versus high–potency statin).
Statin treatment did not affect the incidence of recurrent stroke in patients with cardioembolic stroke.

► Click here to access PubMed, Publisher and related articles.